Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol. [electronic resource]
Producer: 20160930Description: 138-41 p. digitalISSN:- 1873-3492
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.